Search Results - "Reiss, Samantha N"

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas by Reiss, Samantha N, Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian

“…Programmed cell death ligand-1 (PD-L1) expression has been reported in up to 61% of high grade gliomas (HGG). The purpose of this study was to describe safety…”
Get full text

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma by Modelevsky, Lisa, Tizon, Richard, Reiss, Samantha N, Smith, Marcel, Garonce, Rachel, Kaley, Thomas

“…To establish the safety and feasibility of rapidly infusing rituximab over 90 min in patients with primary CNS lymphoma (PCNSL). We retrospectively reviewed…”
Get full text

Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study by Reiss, Samantha N., Yerram, Prakirthi, Modelevsky, Lisa, Grommes, Christian

“…Relapsed/refractory Primary Central Nervous System Lymphoma (R/R PCNSL) has a poor prognosis with no established preferred treatment. We report the efficacy…”
Get full text

Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas by Yerram, Prakirthi, Reiss, Samantha N., Modelevsky, Lisa, Gavrilovic, Igor T., Kaley, Thomas

“…Purpose An increased incidence in hematologic toxicity has been reported with the addition of bevacizumab to lomustine for patients with recurrent or…”
Get full text

Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia by Reiss, Samantha N., Buie, Larry W., Adel, Nelly, Goldman, Debra A., Devlin, Sean M., Douer, Dan

“…As a weak acid, methotrexate (MTX) is bound to serum albumin and has variable protein binding. The purpose of this study was to assess serum albumin’s…”
Get full text

Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City by Yerram, Prakirthi, Thackray, Jennifer, Modelevsky, Lisa R, Land, Josiah D, Reiss, Samantha N, Spatz, Krisoula H, Levoir, Andrea C, Pak, Terry K, Dao, Phuong H, Buege, Michael J, Derespiris, Lauren M, Lau, Carmen, Orozco, Jennifer S, Boparai, Manpreet, Koranteng, Lauren A, Reichert, Kate E, Yan, Shirley Q, Daukshus, Nicole P, Mathew, Sherry, Buie, Larry W, Tizon, Richard F, Freeswick, Scott, Liu, Dazhi, Harnicar, Stephen

“…Purpose With the rapid spread of COVID-19 in New York City since early March 2020, innovative measures were needed for clinical pharmacy specialists to provide…”
Get full text

Abstract P1-07-04: Claims-derived comorbidities associations with real-world overall survival (rwOS) among patients with metastatic breast cancer in an electronic health record-claims linked dataset by Ascha, Mustafa S., Asfaw, Alemseged A., Yerram, Prakirthi, Reiss, Samantha N., Brake, Sarah D., Wadé, Niquelle B.

“…Introduction: Comorbid conditions can significantly impact various aspects of cancer care and therefore are often utilized as covariates to control for…”
Get full text

Hypoalbuminemia Is Significantly Associated with Increased Clearance Time of High Doses of Methotrexate by Reiss, Samantha N., Buie, Larry W., Adel, Nelly G., Goldman, Debra A., Devlin, Sean, Douer, Dan

“…Introduction: Methotrexate is an antimetabolite chemotherapeutic agent used for over 50 years. The inclusion of high dose methotrexate with leucovorin rescue…”
Get full text